The state Duma will ask the Ministry of health about the possibility of simplifying the implementation of the Russian innovative drugs, in particular, the release-active drugs. About it on Tuesday was declared by the first Deputy Chairman of the Duma Committee on health protection, Deputy head of the faction “Fair Russia” Fedot Tumusov, speaking from the faction after the “government hour” with participation of the head of the Ministry of health Veronika Skvortsova.
As reported TASS, “prominent doctors, scientists, government representatives spoke about a very complex system of implementation of the Russian innovative drugs, announced Tumusov. – At the end of the “round table” preparing a parliamentary inquiry to the Ministry of health.”
According to him, “request based on the proposal of the medical branch of RAS on the need to develop science-based regulatory requirements for the new class release-active drugs on the basis of high dilutions of antibodies”.
The first Deputy Chairman of the Duma Committee pointed to the apparent success of the Russian pharmaceutical industry. According to him, is “one of the fastest growing industries in monetary terms, the growth rate is 10-12 percent.” “Taken real measures to ensure adequate quality of medicines”, – said the politician.
The MP drew attention that it is not possible to “remove the issue of providing medicines to individual categories of citizens”. At the same time as the MP stated, the fulfillment of the President of Russia of tasks on increasing of life expectancy of Russians to 78 and then to 80 years “is impossible without the supply of medicines in all categories of the population.”
One of the issues of domestic pharmaceutical Tumusov the fact that the system of registration of medical drugs, which is trying to implement in the near future, more “raw”, not adequately developed. “15% is really high-quality products can now Berkovitsa due to technical problems marking this system”, – said the Deputy.
In April, the participants of the “round table” in the state Duma discussed the problems of legislative regulation and simplification of the registration procedure of drugs. Recommendations following the event, which was attended by representatives of the medical community, the need of a search mechanism, the close interaction of the professional community and authorities for research of medicines and registration of domestic innovative release-active drugs. In particular, speakers at the meeting corresponding member of RAS Oleg Epstein expressed confidence that “the latest class release-active drugs should be legally implemented in the first place in Russia, not the West.”